Amgen Inc. (ETR:AMG)
Germany
· Delayed Price · Currency is EUR | Market Cap | 155.75B |
| Revenue (ttm) | 32.28B |
| Net Income (ttm) | 3.95B |
| Shares Out | n/a |
| EPS (ttm) | 7.30 |
| PE Ratio | 39.42 |
| Forward PE | n/a |
| Dividend | 8.53 (2.96%) |
| Ex-Dividend Date | Feb 14, 2025 |
| Volume | 662 |
| Average Volume | 483 |
| Open | 282.70 |
| Previous Close | 282.40 |
| Day's Range | 283.60 - 287.75 |
| 52-Week Range | 243.30 - 318.05 |
| Beta | 0.56 |
| RSI | 66.44 |
| Earnings Date | Feb 4, 2025 |
About Amgen
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascul... [Read more]
Financial Performance
In 2024, Amgen's revenue was $33.42 billion, an increase of 18.57% compared to the previous year's $28.19 billion. Earnings were $4.09 billion, a decrease of -39.11%.
Financial numbers in USD Financial StatementsNews
Derek Miller Takes Money Off The Table, Sells $593K In Amgen Stock
Revealing a significant insider sell on February 21, Derek Miller , SVP at Amgen (NASDAQ: AMGN), as per the latest SEC filing. What Happened: Miller's decision to sell 2,024 shares of Amgen was revea...
Teva/Alvotech follow Amgen in launching biosimilar for J&J’s Stelara
Amgen, Inc. (AMGN) Citi's 2025 Virtual Oncology Leadership Summit Conference (Transcript)
Looking Into Amgen's Recent Short Interest
Amgen's (NYSE: AMGN) short percent of float has risen 11.27% since its last report. The company recently reported that it has 12.74 million shares sold short , which is 2.37% of all regular shares th...
Amgen Inc (AMGN) to Present at Citi's 2025 Virtual Oncology Leadership Summit
Amgen Inc (AMGN) to Present at Citi's 2025 Virtual Oncology Leadership Summit
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
THOUSAND OAKS, Calif. , Feb. 14, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at Citi's 2025 Virtual Oncology Leadership Summit at 3:00 p.m.
Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript
Amgen Unusual Options Activity For February 12
Deep-pocketed investors have adopted a bearish approach towards Amgen (NASDAQ: AMGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled t...
One 'Safer' Buy In 10 February Dogs Of The Dow
Verizon is the only Dow Dog meeting the ideal of dividends from $1K invested exceeding single share price, supported by adequate free cash flow. Analysts project net gains of 15.23% to 33.94% for the ...
Amgen Inc (AMGN) to Present at Oppenheimer Healthcare Life Sciences Conference
Amgen Inc (AMGN) to Present at Oppenheimer Healthcare Life Sciences Conference
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
THOUSAND OAKS, Calif. , Feb. 7, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 35th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m.
23 Upcoming Dividend Increases, Including 2 Kings
Excited to announce dividend hikes for 23 companies, including dividend kings SJW Group and California Water Service Group, with 5% and 7.1% increases. Companies with consistent dividend growth indica...
Nancy A Grygiel Implements A Sell Strategy: Offloads $483K In Amgen Stock
A substantial insider sell was reported on February 7, by Nancy A Grygiel , SVP & CCO at Amgen (NASDAQ: AMGN), based on the recent SEC filing. What Happened: Grygiel's recent move involves selling 1,...
Amgen: Multiple Strengths, But The Valuation Is A Concern
Jim Cramer reviews 10 stocks leading the Dow now
CNBC's Jim Cramer on Thursday thought it worthwhile to review ten stocks that led the Dow Jones Industrial Average over the past year, including 3M and Amgen.
Amgen Stock Has Surged. Here's Where It's Headed Next.
The stock is up 15% since late December.
Amgen: The Charts Didn't Lie, Upgrade To Buy
Amgen Q4 Earnings: Good Quarter, Ok Guidance, But MariTide Concerns Me (Rating Downgrade)
Amgen Q4 Earnings: Strong Pipeline And Label Expansions Justify Buy Rating
Amgen (AMGN) Stock Jumps on Strong Revenue Results
Amgen (AMGN) Stock Jumps on Strong Revenue Results
Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead
On Tuesday, Amgen Inc (NASDAQ: AMGN) reported fourth-quarter sales of $9.10 billion, up 11% year-over-year, beating the consensus of $8.9 billion . Product sales grew 11%, primarily driven by 14% vol...
Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead
On Tuesday, Amgen Inc AMGN reported fourth-quarter sales of $9.10 billion, up 11% year-over-year, beating the consensus of $8.9 billion.
Amgen Options Trading: A Deep Dive into Market Sentiment
High-rolling investors have positioned themselves bullish on Amgen (NASDAQ: AMGN), and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tr...
Amgen early-stage obesity asset placed on clinical hold
Amgen faces a setback as clinical hold placed on obesity candidate AMG 513. Read more here.
In the kickstart video for Feb 5 the USD is lower as US traders enter the fray for the day
In the kickstart video above, I take a technical look at the 3 major currency pairs - the EURUSD, USDJPY and GBPUSD. The greenback is falling vs each led by declines of over 1% vs the JPY. The USD is ...